The Curative Therapy Cost Multiplier: Determining the Alpha Thalassemia Market Size and Long-Term Value
  The true Alpha Thalassemia Market Size is complex to calculate because it is currently a blend of low-cost, high-volume supportive care and the expected future high-cost, low-volume curative treatments. Historically, the market size was defined by the massive volume of iron chelator sales, driven by the large number of transfusion-dependent patients globally. While individual unit costs...
0 Commentarios 0 Acciones 2K Views 0 Vista previa